Zymo Research's DNA/RNA Shield(TM) Inactivates Monkeypox for the Collection and Transportation of Samples

Zymo Research Corp.

PR97015

 

IRVINE, Calif., July 15, 2022 /PRNewswire=KYODO JBN/ --

 

Zymo Research Corp., in collaboration with the Institute of Virology,

University Medical Center Freiburg, Germany, demonstrated data showing their

DNA/RNA Shield(TM) Inactivating Transport Medium (ITM) completely inactivated

recent Monkeypox virus isolates.

 

Photo - https://mma.prnewswire.com/media/1859786/Zymo_Research_Corp_ITM.jpg

Photo - https://mma.prnewswire.com/media/1859787/Zymo_Research_Corp_Assay.jpg

 

This data comes at a critical time as Monkeypox cases continue to climb

worldwide and scientists are seeking methods to safely collect and transport

samples without compromising the genetic integrity. Monkeypox testing is

primarily performed via PCR from a swabbed lesion.

 

The DNA/RNA Shield(TM) product line includes sample collection, preservation,

and transportation devices for specimens used in research and infectious

disease testing workflows. DNA/RNA Shield(TM) has enabled researchers to

conduct infectious disease research and testing over the past decade, including

throughout the COVID-19 pandemic.

 

Zymo Research offers several devices that can be filled with DNA/RNA

Shield(TM), including the popular SafeCollect(TM) Swab Collection Kit. The

SafeCollect(TM) Swab Collection Kits contain a collection swab and a patented

tube that features a safety seal to prevent accidental spillage, contact,

and/or ingestion of the sample stabilization medium, making it ideal for

at-home sample collection.

 

Learn more about Zymo Research's DNA/RNA Shield SafeCollect(TM) Sample

Collection Kits here (

https://c212.net/c/link/?t=0&l=en&o=3595014-1&h=3396662148&u=https%3A%2F%2Fwww.zymoresearch.com%2Fpages%2Fsafecollect%3Futm_source%3DPRNewswire%26utm_medium%3DPress_Release%26utm_campaign%3DMonkeypox_Press_Release_07.13.22&a=here

).

 

View the data sheet. ( https://tinyurl.com/2chbbh8f )

 

About Zymo Research Corp.

 

Zymo Research is a privately owned company that has been serving the scientific

and diagnostics community with state-of-the-art molecular biology tools since

1994. The company's vision "The Beauty of Science is to Make Things Simple" is

reflected in all of its products, from epigenetics to DNA/RNA purification

technologies. Historically recognized as the leader in epigenetics, Zymo

Research is breaking boundaries with novel solutions for sample collection,

microbiomic measurements, diagnostic devices, and Next-Generation Sequencing

(NGS) technologies that are high quality and simple to use. Follow Zymo

Research on Facebook (

https://c212.net/c/link/?t=0&l=en&o=3595014-1&h=1144873406&u=https%3A%2F%2Fwww.facebook.com%2Fzymoresearch&a=Facebook

), LinkedIn (

https://c212.net/c/link/?t=0&l=en&o=3595014-1&h=3792687520&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzymo-research-corp%2F&a=LinkedIn

), Twitter (

https://c212.net/c/link/?t=0&l=en&o=3595014-1&h=575168204&u=https%3A%2F%2Ftwitter.com%2FZymoResearch&a=Twitter

), and Instagram (

https://c212.net/c/link/?t=0&l=en&o=3595014-1&h=568235130&u=https%3A%2F%2Fwww.instagram.com%2Fzymoresearch%2F&a=Instagram

).

 

SOURCE  Zymo Research Corp.

 

CONTACT: Marketing Department, Zymo Research Corp., 949.679.1190,

marketing@zymoresearch.com

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中